Company Overview
American Healthcare REIT, Inc. operates as a Maryland-based, self-managed Real Estate Investment Trust that owns and manages a diversified portfolio of clinical healthcare properties located across the United States, the United Kingdom, and the Isle of Man. The company functions within the Real Estate sector, specifically the REIT - Healthcare Facilities industry, which involves investing in and operating properties that support healthcare delivery such as senior housing, skilled nursing facilities, and outpatient medical centers. The firm employs a workforce of 121 individuals and currently holds a market capitalization of $8.86B with a trailing twelve-month revenue of $2.26B. These valuation and revenue figures indicate that the company represents a substantial entity within the specialized healthcare real estate market, reflecting a significant asset base and operational scale that supports its broad geographic footprint.
Financial Health
The company generated $2.26B in revenue over the trailing twelve months, resulting in a net income of $69.81M and an EBITDA of $387.24M. The substantial gap between the $2.26B revenue and the $69.81M net income reveals a cost structure where operating expenses, including debt interest and property management costs, consume the majority of gross earnings before arriving at the final bottom line. The business produced $341.35M in free cash flow, which provides the firm with significant financial flexibility to service its obligations, maintain its properties, or pursue strategic acquisitions without relying solely on external financing. Analysis of the three key margins shows a gross margin of 18.3%, an operating margin of 6.7%, and a profit margin of 3.1%, indicating that while the company retains a healthy portion of revenue as gross profit, the final profitability is heavily impacted by fixed costs and leverage. On the liability side, the company holds $114.84M in cash against a total debt load of $1.69B, resulting in a debt-to-equity ratio of 50.20, which suggests a highly leveraged balance sheet typical of REIT structures but one that requires careful monitoring of interest rate environments. Liquidity is assessed via a current ratio of 0.94, which indicates that the company's current assets are slightly lower than its current liabilities, signaling a need to manage working capital efficiently to meet short-term obligations. Finally, the return on equity stands at 2.5% while the return on assets is 2.1%, metrics that reveal management is generating modest returns relative to the capital invested and the total asset base, reflecting the capital-intensive nature of the healthcare facility business.
Valuation Assessment
The stock carries a trailing P/E ratio of 112.21 and a forward P/E of 51.04, implying that the market expects a significant reduction in the price-to-earnings multiple as earnings are anticipated to rise or current high valuations normalize over time. The price-to-book ratio is recorded at 2.64, indicating that the market is pricing the company at a substantial premium over its net asset book value, likely due to the quality of its real estate holdings and stable lease agreements. Alternative valuation metrics such as a price-to-sales ratio of 3.92 and an EV/EBITDA of 27.05 suggest that investors are valuing the firm based on its ability to generate cash flow and sales rather than solely on current earnings, though the high multiples reflect the capital-intensive reality of the asset class. In terms of trading range, the 52-week high is $54.67 and the 52-week low is $26.48, providing a wide band of volatility within which the current price must be situated to determine relative entry or exit points. The beta of 0.94 indicates that the stock's price volatility moves in tandem with the broader market, suggesting it does not exhibit significant defensive characteristics nor extreme amplification of market swings compared to the S&P 500.
Growth & Income
Revenue growth for the trailing twelve months stands at 11.9%, while earnings growth is listed as N/A, which precludes a direct comparison of earnings acceleration against sales expansion in the current reporting period. The company offers a dividend yield of 2.1% but maintains a payout ratio of 238.1%, a figure that mathematically exceeds 100% and indicates that the dividend is being funded from sources other than current net income, such as cash reserves or debt proceeds, rather than organic earnings retention. Given the payout ratio significantly outpaces the reported net income, the dividend sustainability relies heavily on the company's free cash flow generation and asset appreciation rather than traditional earnings retention strategies. The overall profile combines moderate revenue expansion with a high-yield dividend, though the elevated payout ratio suggests the income component carries specific risks regarding its dependency on non-earnings cash sources.